Company
CASI Pharmaceuticals, Inc.
- Legal name
- CASI Pharmaceuticals, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
CASI Pharmaceuticals, Inc. is a U.S. NASDAQ-listed biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products. CASI has built a portfolio that includes approved and investigational assets.
Funding snapshot
- Total raised
- $35MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $5M2026-04-17
Funding rounds
- Round, 2026
- $5M2026-04-17, SEC form D sold, 1 investor
- Round, 2026
- $5M2026-02-19, SEC form D sold, 1 investor
- Round, 2026
- $5M2026-01-09, SEC form D sold, 1 investor
- Round, 2025
- $5M2025-12-27, SEC form D sold, 1 investor
- Round, 2024
- $15M2024-06-26, SEC form D sold, 7 investors
Loading relationship preview